Abstract: Techniques for protecting software in a computing device are provided. A method according to these techniques includes receiving a request from a non-secure software module to execute an instruction of a secure software module comprising encrypted program code, determining whether the instruction comprises an instruction associated with a controlled point of entry to the secure software module accessible outside of the secure software module, executing one or more instructions of the secure software module responsive to the instruction comprising an instruction associated with the controlled point of entry to the secure software module, and controlling exit from the secure software module to return execution to the non-secure software module.

Abstract: In an aspect, a cache memory device receives a request to read an instruction or data associated with a memory device. The request includes a first realm identifier and a realm indicator bit, where the first realm identifier enables identification of a realm that includes one or more selected regions in the memory device. The cache memory device determines whether the first realm identifier matches a second realm identifier in a cache tag when the instruction or data is stored in the cache memory device, where the instruction or data stored in the cache memory device has been decrypted based on an ephemeral encryption key associated with the second realm identifier when the first realm identifier indicates the realm and when the realm indicator bit is enabled. The cache memory device transmits the instruction or data when the first realm identifier matches the second realm identifier.

Abstract: Several features pertain to computing systems equipped to perform speculative processing and configured to access device memory (e.g. non-speculative or unspeculatable memory) and non-device memory (e.g. speculative or speculatable memory). Malicious attacks may seek to obtain sensitive information from such systems by exploiting speculative code execution. Herein, techniques are described whereby sensitive data is protected from such attacks by placing the data in a page of memory not ordinarily used as device memory, and then designating or marking the page as device memory (e.g. marking the page as unspeculatable). By designating the page as unspeculatable device memory, the processor does not speculatively access the sensitive information (e.g. speculation stops once a branch is invoked that would access the page) and so certain types of attacks can be mitigated.

Abstract: In one embodiment, an integrated circuit includes a power management architecture in which one or more pipelines are actively powered and clocked when data is provided for processing, but which are clock gated and in retention when there is no data to be processed. When data is provided to the pipeline, supply voltage may be actively provided to initial stages of the pipeline and the clocks may be ungated when the voltage is stable enough for operation. Subsequent stages of the pipeline may be sequentially provided power and clocks as the data progresses through the pipeline. Initial stages may be clock gated and power may be deactivated when additional data is not provided for processing. Accordingly, when the pipeline is viewed as a whole, power may be seen as rolling forward ahead of the data processing, and power may be inhibited in a similar rolling fashion.

Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.

Abstract: In an aspect, a method for protecting software includes obtaining a payload including at least one of instructions or data, establishing a realm in a memory device, encrypting the payload based on an ephemeral encryption key (EEK) associated with the realm, and storing the encrypted payload in the realm of the memory device. In another aspect, a method for protecting software includes receiving a memory transaction associated with the memory device, the memory transaction including at least a realm identifier (RID) and a realm indicator bit, obtaining the EEK associated with the RID when the RID indicates the realm and when the realm indicator bit is enabled, decrypting an instruction and/or data retrieved from the realm based on the EEK when the memory transaction is a read transaction, and encrypting second data for storage in the realm based on the EEK when the memory transaction is a write transaction.

Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.

Abstract: Aspect may relate to a device that comprises an interface and a processor. The interface may be configured to: obtain a statement from an asserting party exercising an authorization. The processor may be coupled to the interface and the processor may be configured to: implement an evaluator to evaluate the statement from the asserting party with policy verification instructions to determine if the asserting party was authorized to issue the statement.

Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.

Abstract: In one embodiment, an integrated circuit includes a power management architecture in which one or more pipelines are actively powered and clocked when data is provided for processing, but which are clock gated and in retention when there is no data to be processed. When data is provided to the pipeline, supply voltage may be actively provided to initial stages of the pipeline and the clocks may be ungated when the voltage is stable enough for operation. Subsequent stages of the pipeline may be sequentially provided power and clocks as the data progresses through the pipeline. Initial stages may be clock gated and power may be deactivated when additional data is not provided for processing. Accordingly, when the pipeline is viewed as a whole, power may be seen as rolling forward ahead of the data processing, and power may be inhibited in a similar rolling fashion.

Abstract: In an aspect, a method for protecting software includes obtaining a payload including at least one of instructions or data, establishing a realm in a memory device, encrypting the payload based on an ephemeral encryption key (EEK) associated with the realm, and storing the encrypted payload in the realm of the memory device. In another aspect, a method for protecting software includes receiving a memory transaction associated with the memory device, the memory transaction including at least a realm identifier (RID) and a realm indicator bit, obtaining the EEK associated with the RID when the RID indicates the realm and when the realm indicator bit is enabled, decrypting an instruction and/or data retrieved from the realm based on the EEK when the memory transaction is a read transaction, and encrypting second data for storage in the realm based on the EEK when the memory transaction is a write transaction.

Abstract: Techniques for protecting software in a computing device are provided. A method according to these techniques includes receiving a request from a non-secure software module to execute an instruction of a secure software module comprising encrypted program code, determining whether the instruction comprises an instruction associated with a controlled point of entry to the secure software module accessible outside of the secure software module, executing one or more instructions of the secure software module responsive to the instruction comprising an instruction associated with the controlled point of entry to the secure software module, and controlling exit from the secure software module to return execution to the non-secure software module.

Abstract: A system including a tubing hanger running tool (THRT), including one or more stab connectors, and a planetary gear system, wherein the planetary gear system is configured to couple and uncouple the THRT from a first hydrocarbon extraction component.

Abstract: In an aspect, a cache memory device receives a request to read an instruction or data associated with a memory device. The request includes a first realm identifier and a realm indicator bit, where the first realm identifier enables identification of a realm that includes one or more selected regions in the memory device. The cache memory device determines whether the first realm identifier matches a second realm identifier in a cache tag when the instruction or data is stored in the cache memory device, where the instruction or data stored in the cache memory device has been decrypted based on an ephemeral encryption key associated with the second realm identifier when the first realm identifier indicates the realm and when the realm indicator bit is enabled. The cache memory device transmits the instruction or data when the first realm identifier matches the second realm identifier.

Abstract: A method for generating hypotheses in a corpus of data comprises selecting a form of ontology; coding the corpus of data based on the form of the ontology; generating ontology space based on coding results and the ontology; transforming the ontology space into a hypothesis space by grouping hypotheses; weighing hypotheses included in the hypothesis space; and applying a science-based optimization algorithm configured to model a science-based treatment of the weighted hypotheses.

Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.

Abstract: The present invention provides compounds represented by formula (I), pharmaceutically acceptable salts thereof, N-oxides thereof, solvates thereof or prodrugs thereof (wherein the characters are as defined in the description). The compounds represented by formula (I) have affinity and selectivity for the gamma-aminobutyric acid A receptor subunit alpha 5 (GABAA ?5) and act as GABAA ?5 negative allosteric modulators (GABAA ?5 NAM), so that they are useful in the prevention and/or treatment of diseases which are related to the GABAA ?5 such as Alzheimer's disease.

Abstract: Systems, apparatuses, and methods for preventing charge accumulation on a display panel of a display. A display pipeline is configured to drive a display using a variable frame refresh rate. The display may also be driven by a polarity inversion cadence to alternate the polarity on the display panel on back-to-back frames. In some cases, the frame refresh rate cadence, as specified in frame packets which contain configuration data for processing corresponding frames, can cause a charge accumulation on the display panel if an odd number of frames are displayed at a first frame refresh rate before switching to a second frame refresh rate. Accordingly, in these cases, the display pipeline may override the frame refresh rate setting for a given frame to cause an even number of frames to be displayed at the first frame refresh rate.

Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.

Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.